B. Riley Securities Reiterates Buy on Precigen, Lowers Price Target to $11

Benzinga · 2d ago
B. Riley Securities analyst Yuan Zhi reiterates Precigen (NASDAQ:PGEN) with a Buy and lowers the price target from $12 to $11.